SSA and Boehringer Ingelheim Acute Stroke Research Innovation Grant 2019

The Stroke Society of Australasia Annual Conference 2019 and Boehringer Ingelheim Stroke Research Innovation Grant aim to support break-through research that contribute to the diagnosis and management of acute stroke. Together, our goal is to further reduce the burden of stroke in Australia and New Zealand.

Applications are now closed. 


Funding and Eligibility

AUD40 000 grant is available to early-to-mid stage researchers and healthcare professionals wanting to pursue research in stroke medicine with emphasis on diagnosis and management of acute stroke.

Eligible applicants must be:

  • A member of the Stroke Society of Australasia (or have an application for membership pending by grant closing date)
  • Six years or less post-award of PhD or postgraduate qualification
  • Domiciled in Australia or New Zealand
  • Affiliated with academic/scientific institution or national health care system

Scope of Grant

Both interventional and observational studies within the following fields will be considered:

  • Criteria 1: Novel techniques in stroke diagnostics
  • Criteria 2: Medical therapeutics in stroke

Out-of-scope grants are:

  • Studies involving basic animal research
  • Studies replicating findings of completed Phase IV or on-going large scale clinical trials

The research project must have publishable data/outcomes within 18 to 24 months from award.

Conduct of research and clearance requirements

Safeguarding the rights and welfare of human subjects involved in research during the tenure of the SSA 2019 research grant is the responsibility of the scholar and of the institution in which the award is tenable. Research shall be conducted in accordance with the NHMRC Australian Code for the Responsible Conduct of Research (2018). In New Zealand, research must comply with the National Ethics Advisory Committee guidelines for intervention and observation studies.

Clearances for research of any of the following shall be obtained from the appropriate Ethics Committee:

  1. Humans: Any human experimentation shall be conducted in accordance with the current requirements of the NHMRC National Statement on Ethical Conduct in Human Research, 2007 (updated 2018): clearance must be obtained from the appropriate institutional Human Research Ethics Committee.


Eligible applicants must complete the relevant grant application form, in addition to providing the below supporting documentation:

  • Project outline (max 1000 words)
  • Two-page Curriculum vitae
  • List of publications in the last 6 years
  • Letter of support from supervisor
  • Ethics approval of project by institutional human research ethics committee

Applications are now closed. Recipients will be notified 16th August 2019.

Review process

All grant applications will be reviewed by the SSA 2019 Annual Conference Scientific Committee. The application and review processes are entirely independent of Boehringer Ingelheim.

Announcement of grant winners

The grant winners will be announced to the public on Friday 13th September 2019 at the SSA Conference held in Canberra from 10-13 September 2019. You will be notified if you are the winner shortly prior to the conference to prepare a brief presentation.

For further information regarding the grant or your application, please contact us by phone +61 7 3858 5400 or email at [email protected].